Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis

doi:10.3748/wjg.v18.i30.4004

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10445)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-8) series.

Item

Count

PDF

785

HTML

9140

Figures (1-3)

262

Tables (1-8)

258

Sum=10445

Aug 14, 2012 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (40)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 14, 2012; 18(30): 4004-4011
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.4004

Full Size Figure Download Figure

Figure 1 Faecal pyruvate kinase isoenzyme type M2 in healthy controls, patients with colorectal adenoma and colorectal cancer[51]. Faecal M2-PK: Faecal pyruvate kinase isoenzyme type M2.

Citation: Tonus C, Sellinger M, Koss K, Neupert G. Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis. World J Gastroenterol 2012; 18(30): 4004-4011
URL: https://www.wjgnet.com/1007-9327/full/v18/i30/4004.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i30.4004